Welleman I, ReeBing F, Boersma H, Dierckx R, Feringa B, Szymanski W
Pharmaceuticals (Basel). 2023; 16(10).
PMID: 37895910
PMC: 10610007.
DOI: 10.3390/ph16101439.
Geraldes C, Peters J
Molecules. 2022; 27(23).
PMID: 36500389
PMC: 9735696.
DOI: 10.3390/molecules27238297.
Gilad A, Bar-Shir A, Bricco A, Mohanta Z, McMahon M
NMR Biomed. 2022; 36(6):e4712.
PMID: 35150021
PMC: 10642350.
DOI: 10.1002/nbm.4712.
Kovacs A
ACS Omega. 2021; 6(20):13321-13330.
PMID: 34056480
PMC: 8158830.
DOI: 10.1021/acsomega.1c01292.
Laine S, Morfin J, Galibert M, Aucagne V, Bonnet C, Toth E
Molecules. 2021; 26(8).
PMID: 33918899
PMC: 8069257.
DOI: 10.3390/molecules26082176.
Applications for Transition-Metal Chemistry in Contrast-Enhanced Magnetic Resonance Imaging.
Gupta A, Caravan P, Price W, Platas-Iglesias C, Gale E
Inorg Chem. 2020; 59(10):6648-6678.
PMID: 32367714
PMC: 8047401.
DOI: 10.1021/acs.inorgchem.0c00510.
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.
Wahsner J, Gale E, Rodriguez-Rodriguez A, Caravan P
Chem Rev. 2018; 119(2):957-1057.
PMID: 30350585
PMC: 6516866.
DOI: 10.1021/acs.chemrev.8b00363.
An enzyme-activatable and cell-permeable Mn-porphyrin as a highly efficient MRI contrast agent for cell labeling.
Haedicke I, Li T, Zhu Y, Martinez F, Hamilton A, Murrell D
Chem Sci. 2018; 7(7):4308-4317.
PMID: 30155077
PMC: 6013825.
DOI: 10.1039/c5sc04252f.
Assessments of tumor metabolism with CEST MRI.
Goldenberg J, Pagel M
NMR Biomed. 2018; 32(10):e3943.
PMID: 29938857
PMC: 7377947.
DOI: 10.1002/nbm.3943.
Protonation of carboxyl groups in EuDOTA-tetraamide complexes results in catalytic prototropic exchange and quenching of the CEST signal.
Zhang L, Evbuomwan O, Tieu M, Zhao P, Martins A, Sherry A
Philos Trans A Math Phys Eng Sci. 2017; 375(2107).
PMID: 29038382
PMC: 5647270.
DOI: 10.1098/rsta.2017.0113.
Double agents and secret agents: the emerging fields of exogenous chemical exchange saturation transfer and T-exchange magnetic resonance imaging contrast agents for molecular imaging.
Daryaei I, Pagel M
Res Rep Nucl Med. 2016; 5:19-32.
PMID: 27747191
PMC: 5064441.
DOI: 10.2147/RRNM.S81742.
Diamagnetic Imaging Agents with a Modular Chemical Design for Quantitative Detection of β-Galactosidase and β-Glucuronidase Activities with CatalyCEST MRI.
Fernandez-Cuervo G, Tucker K, Malm S, Jones K, Pagel M
Bioconjug Chem. 2016; 27(10):2549-2557.
PMID: 27657647
PMC: 6013409.
DOI: 10.1021/acs.bioconjchem.6b00482.
Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRI.
Sinharay S, Randtke E, Jones K, Howison C, Chambers S, Kobayashi H
Magn Reson Med. 2016; 77(5):2005-2014.
PMID: 27221386
PMC: 5123981.
DOI: 10.1002/mrm.26278.
Advances in Magnetic Resonance Imaging Contrast Agents for Biomarker Detection.
Sinharay S, Pagel M
Annu Rev Anal Chem (Palo Alto Calif). 2016; 9(1):95-115.
PMID: 27049630
PMC: 4911245.
DOI: 10.1146/annurev-anchem-071015-041514.
Detection of Sulfatase Enzyme Activity with a CatalyCEST MRI Contrast Agent.
Sinharay S, Fernandez-Cuervo G, Acfalle J, Pagel M
Chemistry. 2016; 22(19):6491-5.
PMID: 26956002
PMC: 4877021.
DOI: 10.1002/chem.201600685.
A CatalyCEST MRI Contrast Agent that Can Simultaneously Detect Two Enzyme Activities.
Fernandez-Cuervo G, Sinharay S, Pagel M
Chembiochem. 2015; 17(5):383-7.
PMID: 26693680
PMC: 4814164.
DOI: 10.1002/cbic.201500586.
A single diamagnetic catalyCEST MRI contrast agent that detects cathepsin B enzyme activity by using a ratio of two CEST signals.
Hingorani D, Montano L, Randtke E, Lee Y, Cardenas-Rodriguez J, Pagel M
Contrast Media Mol Imaging. 2015; 11(2):130-8.
PMID: 26633584
PMC: 4882611.
DOI: 10.1002/cmmi.1672.
Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.
Benz M, Vargas H, Sala E
Magn Reson Imaging Clin N Am. 2015; 24(1):1-10.
PMID: 26613872
PMC: 5031083.
DOI: 10.1016/j.mric.2015.08.001.
A cell-permeable gadolinium contrast agent for magnetic resonance imaging of copper in a Menkes disease model.
Que E, New E, Chang C
Chem Sci. 2014; 3(6):1829-1834.
PMID: 25431649
PMC: 4243178.
DOI: 10.1039/C2SC20273E.
A review of responsive MRI contrast agents: 2005-2014.
Hingorani D, Bernstein A, Pagel M
Contrast Media Mol Imaging. 2014; 10(4):245-65.
PMID: 25355685
PMC: 4414668.
DOI: 10.1002/cmmi.1629.
